Viveon Health Acquisition (VHAQ) Return on Assets ROA from the first quarter of 2023 to first quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Viveon Health Acquisition Corp   (NYSE: VHAQ)


Viveon Health Acquisition 's ROA from the first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Viveon Health Acquisition 's ROA in the first quarter of 2023?
Viveon Health Acquisition Corp achieved a return on average assets (ROA) of 2.63 % in its first quarter of 2023, this is above VHAQ's average return on assets of -1.15%.
Viveon Health Acquisition Corp assets over the 12 months ending in its first quarter of 2023 are valued at $45 million

Despite the company's net income deteriorating, Viveon Health Acquisition was able to improve its ROA compared to the fourth quarter of 2022.

However, within the Healthcare sector 168 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2023 quarter, so far to 1860, from total ROA ranking in the fourth quarter of 2022 at 3609.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Total Assets Change -62.18 % -73.91 % -73.95 % -73.88 % 2571.16 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 1 -1 -5 -2 -4
Return On Assets (TTM) 2.63 % -1.14 % -5.83 % -1.35 % -2.45 %
VHAQ's Total Ranking # 1860 # 3609 # 3638 # 3309 # 3363
Total Assets (TTM) in million 20 53 53 53 53
Seq. Total Assets Change -62.16 % -0.16 % -0.44 % 0.56 % -73.9 %
Seq. Net Income Change -90.71 % - - - -

VHAQ's 5 Years Annual ROA >> Back to VHAQ Management Effectiveness >> Compare VHAQ ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 64
Sector # 169
Overall # 1825

Return On Assets Statistics
High Average Low
2.61 %
-1.15 %
-5.82 %
(Mar 31 2023)   (Sep 30 2022)





Financial Statements
Viveon Health Acquisition 's Assets $ 20 million VHAQ's Balance sheet
Viveon Health Acquisition 's Income $ 0 million Quarterly VHAQ's Income Statement
VHAQ's Income by Division See VHAQ's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020
FY
FY
Y / Y Total Assets Change -73.91 % -1.74 % - - -
Total Assets in million 53 203 207 0 0
Y / Y Net Income Change - - - - -
Net Income in million -1 2 -2 0 0
Annual Return On Assets -1.14 % 1.22 % -1.08 % - -

VHAQ's 5 Years Annual ROA >> Back to VHAQ Management Effectiveness >> Compare VHAQ ROA to its Competitors



More Return On Assets Ratios
VHAQ's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VHAQ's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VHAQ's Competitors
Subscribers only: Roa for Viveon Health Acquisition 's Suppliers
Subscribers only: Return On Assets for VHAQ's Customers

You may also want to know
VHAQ's Roi VHAQ's Inventory Turnover Ratio VHAQ's Growth Rates VHAQ's Dividend Comparisons
VHAQ's Profitability Ratios VHAQ's Asset Turnover Ratio VHAQ's Dividend Growth
VHAQ's Roe VHAQ's Valuation Ratios VHAQ's Financial Strength Ratios VHAQ's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2023, within Healthcare Sector ROA
Patterson Companies Inc   7.21 %
Stryker Corp  7.21 %
Organon and Co   6.98 %
Johnson and Johnson  6.91 %
Prophase Labs Inc   6.88 %
Fonar Corporation  6.85 %
Ensign Group Inc  6.85 %
Lemaitre Vascular Inc   6.73 %
Charles River Laboratories International inc   6.64 %
Orasure Technologies Inc  6.63 %
Docgo Inc   6.62 %
Quest Diagnostics Inc  6.59 %
Rayont Inc   6.55 %
Repligen Corp  6.19 %
Haemonetics Corporation  6.17 %
Encompass Health Corporation  6.17 %
Electromed Inc   6.07 %
Escalon Medical Corp   6.05 %
Cadre Holdings inc   6.03 %
Henry Schein Inc   5.97 %
Incyte Corporation  5.77 %
Acadia Healthcare Company Inc   5.73 %
Amedisys Inc  5.61 %
Dexcom Inc   5.57 %
Abbvie Inc   5.44 %
Integrated Biopharma Inc  5.43 %
Align Technology inc   5.35 %
Addus Homecare Corp  5.32 %
Teleflex Incorporated  5.31 %
Third Harmonic Bio Inc   5.26 %

Date modified: 2026-09-08T15:11:17+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.